Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
前收盤價
US$0.51
−US$0.0278 · -5.17%
盤後
US$0.509
−US$0.001 · -0.20%
10月12日 下午7:30 ET
盤中時間採用ET。市場資料可能有所延遲。
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
日內區間
目前US$0.51
52週區間
目前US$0.51
盤中時間採用ET。市場資料可能有所延遲。
GoAI 評分
賣出
估值
55
合理估值
情緒
50
多空交錯
風險
71
高風險
動能
17
強勢下行
完整 GoAI 研究
繼續查看更深入的依據、催化因素和風險。
Nano-X Imaging Ltd. specializes in developing a commercial-grade tomographic imaging device that incorporates an innovative digital X-ray source, which leverages a digital micro-electro-mechanical systems (MEMS) semiconductor cathode. Beyond its hardware focus, the company also delivers teleradiology services and creates artificial intelligence (AI) applications tailored for practical use in medical imaging. Its core offerings include the Nanox.ARC, a prototype medical imaging system that integrates its proprietary digital X-ray technology, and Nanox.CLOUD, a complementary cloud-based software platform envisioned to facilitate medical screening as a service. Nano-X also operates Nanox.MARKETPLACE, a platform designed to connect imaging facilities and customers with radiologists for efficient remote interpretation of medical scans. Additionally, the company provides AI-driven software solutions to a wide range of healthcare entities, including hospitals, health maintenance organizations, integrated delivery networks, pharmaceutical companies, and insurers. These solutions are designed to analyze data from existing computed tomography (CT) scans to identify or predict undiagnosed or underdiagnosed medical conditions, such as osteoporosis and cardiovascular disease. Nano-X further offers Teleradiology Services, delivering remote imaging interpretation to radiology practices, hospitals, medical clinics, diagnostic imaging centers, urgent care facilities, and multi-specialty physician groups. Founded in 2011, Nano-X Imaging Ltd. is headquartered in Neve Ilan, Israel.
日內區間
目前US$0.51
52週區間
目前US$0.51
獲利能力占已公布營收的百分比。
營收
營業利益
淨利
| 項目(USD) | 2025會計年度 | 2024會計年度 | 2023會計年度 | 2022會計年度 | 2021會計年度 |
|---|---|---|---|---|---|
| 營收 | 1302.1萬 USD | 1128.3萬 USD | 990.5萬 USD | 857.8萬 USD | 130.4萬 USD |
| 銷貨成本 | 2580.9萬 USD | 2189.2萬 USD | 1649.7萬 USD | 1545.8萬 USD | 281.6萬 USD |
| 毛利 | −1278.8萬 USD | −1060.9萬 USD | −659.2萬 USD | −688萬 USD | −151.2萬 USD |
| 研究與開發 | 1923.6萬 USD | 2018.2萬 USD | 2604.9萬 USD | 2650.7萬 USD | 1712.2萬 USD |
| 銷售、一般及管理費用 | 2709.9萬 USD | 2574.9萬 USD | 2839.4萬 USD | 4563萬 USD | 4174.2萬 USD |
| 營業費用 | 4791.1萬 USD | 4613.7萬 USD | 5599.7萬 USD | 7232.8萬 USD | 6004.6萬 USD |
| 利息收入 | 142.4萬 USD | 287萬 USD | 165.2萬 USD | 78.9萬 USD | — |
| 利息支出 | — | — | — | — | 28.8萬 USD |
| 折舊和攤銷 | 1169.7萬 USD | 1173.3萬 USD | 1181萬 USD | 1151.2萬 USD | 229.2萬 USD |
| 營業利益 | −6069.9萬 USD | −5674.6萬 USD | −6258.9萬 USD | −1.1億 USD | −6155.8萬 USD |
| 淨利 | −7501.8萬 USD | −5351.6萬 USD | −6077.6萬 USD | −1.05億 USD | −6179.8萬 USD |
公司資料更新於 2026年10月13日。
近期已公布業績
近期已公布業績
第三方分析師預期可能變動,並非 GoAI 建議。
平均目標
US$3.00
上漲空間 488.24%價格歷史記錄不可用
最高:US$3.00平均的:US$3.00最低:US$3.00報告持有此股票曝險的交易所交易基金。
AI 生成內容及延遲市場資料僅供資訊與教育用途,不構成投資建議。